Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Arcturus Therapeutics Holdings Inc
(NQ:
ARCT
)
23.55
-0.24 (-1.01%)
Streaming Delayed Price
Updated: 2:31 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcturus Therapeutics Holdings Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 9, 2023
April 26, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 30, 2023
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...
Via
Benzinga
Why Arcturus Therapeutics Stock Is Soaring Today
March 29, 2023
Investors liked what they heard in its Q4 update.
Via
The Motley Fool
Arcturus Therapeutics's Return On Capital Employed Insights
March 29, 2023
Via
Benzinga
A Preview Of Arcturus Therapeutics's Earnings
March 27, 2023
Via
Benzinga
Sprinklr, EVgo, Emergent BioSolutions And Other Big Stocks Moving Higher On Thursday
March 30, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
RH, Semtech And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
March 30, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Semtech Corporation (NASDAQ: SMTC) shares dipped 12.7% to $28.00 in...
Via
Benzinga
S&P 500 Up 1%; Bluebird Bio Shares Plummet
March 29, 2023
U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining over 1% on Wednesday. The Dow traded up 0.74% to 32,632.35 while the NASDAQ rose 1.51% to 11,893.07. The S&P 500, also...
Via
Benzinga
Stocks Rise As Investors Bet On Bank Recovery
March 29, 2023
Stocks are swinging higher today, as bond yields retreat and Wall Street bets that the worst of the regional banking crisis is in the rearview mirror.
Via
Talk Markets
Arcturus Therapeutics's Return On Capital Employed Overview
December 15, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 29, 2023
Via
Benzinga
Arcturus Therapeutics Ltd. (NASDAQ: ARCT) Leading the Way in Wednesday Trading Based on Percentage Gain
March 29, 2023
Via
Investor Brand Network
Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 29, 2023
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million.
Via
Benzinga
Nasdaq Rises 1%; US Pending Home Sales Increase In February
March 29, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 100 points on Wednesday. The Dow traded up 0.58% to 32,580.89 while the NASDAQ rose 1.09% to 11,843.85. The S&P...
Via
Benzinga
Arcturus Therapeutics Stock Is Rising Wednesday: What's Going On?
March 29, 2023
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) shares are trading higher Wednesday after the company reported strong fourth-quarter results and provided an update on pipeline progress.
Via
Benzinga
US Stocks Open Higher, Dow Jumps Over 200 Points
March 29, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining over 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.72% to 32,628.42 while the NASDAQ rose 1.33%...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 29, 2023
Via
Benzinga
Why Shift Technologies Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket
March 29, 2023
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares rose 36.7% to $0.1914 in pre-market trading after the company reported strong revenue and margin growth for the year ended 2022.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 29, 2023
We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on!
Via
InvestorPlace
Cal-Maine Foods, Lululemon Athletica And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
March 29, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Why Arcturus Therapeutics Shares Are Moving Higher After Hours
March 28, 2023
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) shares are booming in Tuesday's after-hours session after the company reported fourth-quarter results and provided an update on
Via
Benzinga
Arcturus Therapeutics Announces Fourth Quarter 2022 Financial Update and Pipeline Progress
March 28, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on March 28, 2023
March 07, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics to Attend Upcoming Investor Conferences
February 06, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics Announces Clinical Trial Application for ARCT-032 Received Approval to Proceed into First-in-Human Studies to Treat Cystic Fibrosis
January 31, 2023
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 19, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Arcturus Appoints John Markels, Ph.D. to its Board of Directors
December 13, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
Why CSL Ltd Stock Could Be Worth a Look
December 03, 2022
FDA approval of costly--but worthwhile--drug leads the momentum that could make CSL Ltd an equally worthwhile investment.
Via
MarketBeat
Exposures
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
November 10, 2022
Upgrades
Via
Benzinga
Arcturus Therapeutics Announces Third Quarter 2022 Financial Update and Pipeline Progress
November 09, 2022
From
Arcturus Therapeutics Holdings Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.